| ID | Name | CAS | Data |
MW (g/mol) |
| 47-380-8 |
3-Buten-2-one, 4-(2,6,6-trimethyl-2-cyclohexen-1-yl), PFBO # 1
|
|
4 | 387.39 |
| 47-566-2 |
Iron,[(2,3,5,6-«eta»)-bicyclo[2.2.1]hepta-2,5-diene]tricarbonyl-
|
12307-07-2 |
4 | 232.01 |
| 47-657-1 |
3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-
|
|
4 | 324.38 |
| 47-807-4 |
Cholest-8-en-3-ol, 14-methyl-, (3.beta.,5.alpha.)-
|
|
4 | 400.69 |
| 48-027-9 |
Benzamide, 2,5-dichloro-n-cyanomethyl-n-ethyl-3-nitro-
|
|
4 | 302.12 |
| 48-043-1 |
O,O-Dimethyl O-(2,4,5-trichloro)phenyl phosphate
|
3983-45-7 |
4 | 305.48 |
| 48-051-2 |
Spiro[8,8-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2,2'-cyclohexanone-1]
|
|
4 | 246.39 |
| 48-387-0 |
7-isopropyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene (ITBD)
|
|
4 | 181.28 |
| 48-545-4 |
Carbamic acid, dimethyl-, 2-(formylmethylamino)-5,6-dimethyl-4-pyrimidinyl ester
|
27218-04-8 |
4 | 252.27 |
| 48-699-4 |
Furan-2(3h)-one, 5- (bromomethyl)-4,5-dihydro-3-(o-hydroxyphenyl)-3-phenyl-
|
94574-85-3 |
4 | 347.20 |
| 48-744-3 |
2-Methoxy-4,6-bis(2-fluoro-2,2-dinitroethoxy)-1,3,5-triazine
|
|
4 | 415.18 |
| 48-768-7 |
1,2-DIHYDRO-4-METHOXYMETHYL-6-METHYL-2-OXO-3-PYRIDINECARBONITRILE
|
|
4 | 178.19 |
| 49-242-9 |
5-Amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-(trifluoromethylsulfinyl)pyrazole-3-carbonitrile
|
|
4 | 437.15 |
| 49-527-3 |
3,7-Diphenyl-5-(p-dimethylaminophenyl)-1,2(4H)-diazepine
|
|
4 | 365.48 |
| 49-566-0 |
Androst-2,4-dien-3,17«beta»-diol, (3,17-O)-diTBDMSi
|
|
4 | 516.95 |
| 49-725-3 |
N-isobutyl-2-(trimethylsilyloxy]-4,5-dihydro-1H-imidazole-1-carboxamide
|
|
4 | 257.40 |
| 49-780-2 |
2,3A-ethanoindan, 3a,4,5,6-tetrahydro-1,1,4,4-tetramethyl-
|
17015-38-2 |
4 | 204.35 |
| 49-927-9 |
3,3,7,11-TETRAMETHYLTRICYCLO[5.4.0.0(4,11)]UNDECAN-1-OL
|
|
4 | 222.37 |
| 50-109-5 |
2H-1-Benzopyran-2-one, 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthalenyl)-
|
5836-29-3 |
4 | 292.33 |
| 50-501-9 |
5«beta»-Androstan-17-one, 3«alpha»,11«beta»-bis(trimethylsiloxy)-
|
17562-89-9 |
4 | 450.80 |
| 50-917-8 |
Silane, [[(17«beta»)-2-methoxyestra-1,3,5(10)-triene-3,17-diyl]bis(oxy)]bis[trimethyl-
|
29825-47-6 |
4 | 446.77 |
| 51-050-9 |
7, 7-Dimethoxy-1, 4, 5, 6-tetrachlorobicyclo [2. 2. 1]-5-heptene-2-carboxylic acid
|
124715-79-3 |
4 | 336.00 |
| 51-399-3 |
Nonanedioic acid, bis(8,8-dimethyl-2-oxabicyclo[4.2.0]octan-7-yl) ester
|
100996-43-8 |
4 | 464.63 |
| 51-409-1 |
17-Epimetandienone (Androst-1,4-dien-17B-methyl-17A-ol-3-one), TMS
|
|
4 | 372.62 |
| 51-567-6 |
1,2,4a,6a,6b,9-Hexamethyl-1,2,3,4,4 a,5,6,6a,6b,7,8,12b,13,14b-tetradecahydro-picene
|
|
4 | 376.63 |
| 51-755-7 |
17«alpha»,20«beta»,21-Trihydroxypregn-4-en-3-one, methylboronate
|
|
4 | 372.31 |
| 52-095-9 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 3,6-dimethyl-
|
|
4 | 174.20 |
| 52-267-8 |
Trichothec-9-ene-3,4,8,15-tetrol, 12,13-epoxy-, 15-acetate 8-(3-methylbutanoate), (3«alpha»,4«beta»,8«alpha»)-
|
|
4 | 424.49 |
| 52-758-3 |
Silane, dimethyl(trans-3,7-dimethyl-2,6-octadien-1-yloxy)nonyloxy-
|
|
4 | 354.64 |
| 52-766-4 |
5«beta»-Cholane-3«alpha»,7«alpha»,24-triol, TMS
|
|
4 | 595.13 |
| 53-503-4 |
Methyl 17A-hydroxy-3-oxoandrost-4-ene-17B-carboxylate, 3-MO
|
|
4 | 375.51 |
| 53-570-0 |
17.alpha.,21-Dihydroxypregn-4-en-3,20-dione, 17,21-dimethylsilylene
|
|
4 | 402.61 |
| 53-652-9 |
17-«alpha»-Hydroxy-17-«beta»-methyl-5-«beta»-androstan-3-one, 17-TMS
|
|
4 | 376.65 |
| 54-704-0 |
2-Cyclopenten-1-one, 2-(2-butenyl)-4-hydroxy-3-methyl-, (Z)-
|
|
4 | 166.22 |
| 54-822-9 |
2,6-Difluoro-3-methylbenzoic acid, 3,4-dichlorophenyl ester
|
|
4 | 317.12 |
| 54-943-5 |
O-methyl,o-(2,4,5,-trichlorophenyl)-tert-butyl phosphoramidothioate
|
16805-76-8 |
4 | 362.64 |
| 54-970-5 |
Silane, dimethyl(dimethyl(2,5-dichlorophenyloxy)silyloxy)(2,5-dichlorophenoxy)-
|
|
4 | 456.30 |
| 55-107-2 |
1H-Inden-4,7-diol, 2,4,5,6,7,7a-hexahydro-2,7-dimethyl-5-methylene-6-cyclopropano-4a,2-oxamethyleno
|
|
4 | 250.34 |
| 55-165-8 |
Cyclohexane, 1-methyl-4-(1-methylethyl)-1,2-bis-(methylthio)
|
|
4 | 232.46 |
| 55-172-0 |
Silane, dimethyl(trans-3,7-dimethyl-2,6-octadien-1-yloxy)heptyloxy-
|
|
4 | 326.60 |
| 55-885-9 |
Glutaric acid, 2-methylhex-3-yl 3-nitro-4-methoxybenzyl ester
|
|
4 | 395.45 |
| 56-004-5 |
17«alpha»,20«beta»,21-Trihydroxypregn-4-en-3-one, bis-TMS
|
|
4 | 492.84 |
| 56-144-0 |
3«alpha»-hydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
4 | 548.99 |
| 56-164-8 |
5«beta»-Androst-1-ene-3,17-dione, mono-TMS
|
|
4 | 358.59 |
| 56-352-9 |
21H,23H-Porphine-2,7,12,17-tetrapropanoic acid, 3,8,13,18-tetramethyl-, tetramethyl ester
|
25767-20-8 |
4 | 710.82 |
| 56-449-2 |
1,3-Di(p-nitrobenzyl)-5-amyl-5-ethylbarbituric acid
|
116465-41-9 |
4 | 496.51 |
| 56-689-6 |
Bicyclo[2.2.1]hept-5-en-2-ol, 2-ethenyl-, (exo)-
|
|
4 | 136.19 |
| 56-707-5 |
3-Cyano-5-(cyanofurazanyl)-1,2,4-oxadiazole N-oxide
|
|
4 | 204.10 |
| 56-753-4 |
7,14-Methano-4H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocin-4-one, dodecahydro-, [7S-(7«alpha»,7a«alpha»,14«alpha»,14a«alpha»)]-
|
486-87-3 |
4 | 248.36 |
| 57-025-1 |
L-Ethionine, N(O,S)-ethoxycarbonyl, (S)-(+)-3-methyl-2-butyl ester
|
|
4 | 305.44 |
| 57-095-4 |
3H-Cyclopenta[a]pentalen-3-one-1,2,3a,5,6,6a,7,7a-octahydro-3a,5,5-trimethyl-(3a.«alpha»,6a.«beta»,7a.«alpha»)
|
|
4 | 204.31 |
| 57-129-6 |
2H-1,3,5-Thiadiazine-2-thione, tetrahydro-3,5-dimethyl-
|
|
4 | 162.28 |
| 57-449-1 |
2,4,6-Tris(2-fluoro-2,2-dinitroethoxy)-1,3,5-triazine
|
28820-59-9 |
4 | 537.19 |
| 57-666-0 |
Androst-4-en-3-one, 17-[(trimethylsilyl)oxy]-, (17«alpha»)-
|
16134-45-5 |
4 | 360.61 |
| 58-070-0 |
Bicyclo[2.4.0]octan-2-one, 3,3-dimethyl-5-oxa-
|
|
4 | 154.21 |
| 58-182-6 |
2-Thiopheneacetic acid, 2-methyloct-5-yn-4-yl ester
|
|
4 | 264.38 |
| 58-327-5 |
(1,4,5,6,7,7-Hexachlorobicyclo[2.2.1]hept-5-en-2-yl)methanol
|
|
4 | 330.85 |
| 58-411-1 |
Acetamide, N-[2-[3,4-bis(acetyloxy)phenyl]-2-hydroxyethyl]-N-methyl-
|
55712-68-0 |
4 | 309.31 |
| 59-004-2 |
2-Butanone, 4-(2,6,6-trimethyl-2-cyclohexen-1-yl), PFBO # 1
|
|
4 | 389.41 |
| 59-016-9 |
3,3-Dimethyl-5-0xa bicyclo[2.4.0]octan-2-ol
|
|
4 | 156.23 |
| 59-197-9 |
2,7-Dimethylbenzo-[1,2-d,5,4-d]bisoxazole
|
|
4 | 188.19 |
| 59-250-9 |
6,6,12,12-Tetramethyl-1,4,8,11-tetroxadispiro-[4.1.4.1]dodecane
|
|
4 | 228.29 |
| 59-414-7 |
1-Benzoxepin-5-carboxylic acid,2,3,4,5-tetrahydro-3-hydroxy-5-phenyl-,gamma-lactone
|
94540-95-1 |
4 | 266.29 |
| 59-692-9 |
2H-Imidazo[4,5-b]pyridin-2-one, 1,3-dihydro-
|
|
4 | 135.13 |
| 59-731-5 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, ethyl ester
|
|
4 | 345.32 |
| 59-846-8 |
3H-Pyrazol-3-one, 2,4-dihydro-2-methyl-5-phenyl-
|
41927-50-8 |
4 | 174.20 |
| 59-880-0 |
Methyltestosterone (Androst-4-en-17A-methyl-17B-ol-3-one), TMS
|
|
4 | 446.81 |
| 59-946-7 |
1,3,5-Cyclohexanetriol, 2,2,4,4,6,6-hexamethyl-
|
|
4 | 216.32 |
| 60-247-1 |
2,6-Pyridinedicarboxylic acid, 4-bromo-2-methoxybenzyl ethyl ester
|
|
4 | 394.22 |
| 60-509-0 |
2-Thiopheneacetic acid, 2,6-dimethylnon-1-en-3-yn-5-yl ester
|
|
4 | 290.42 |
| 60-846-6 |
9H-purine, 6-chloro-9-(2',3'-o-isopropylidene-beta-d-ribofuranosyl)-
|
39824-26-5 |
4 | 326.74 |
| 60-850-1 |
Phosphorothioic acid, O,O-diethyl O-(p-methylsulfonyl)phenyl ester
|
14255-72-2 |
4 | 324.35 |
| 60-914-0 |
7-ethyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene (ETBD)
|
|
4 | 167.26 |
| 61-252-4 |
2-Butanone, 4-(2,6,6-trimethyl-2-cyclohexen-1-yl), PFBO # 2
|
|
4 | 389.40 |
| 61-596-3 |
1,2,3-Trimethyltetrahydro-1,3,2-diazaphosphole 2-oxide
|
16606-18-1 |
4 | 148.14 |
| 61-991-4 |
1,3-Disiloxane, 1,3-diethoxy, 1,3-bis-(ethenyl), 1,3-bis-(chloromethyl)
|
|
4 | 315.34 |
| 62-292-9 |
Heptanoic acid, 2,2,4-trimethyl-3-hydroxy-, beta-lactone
|
|
4 | 170.25 |
| 62-409-9 |
N-tert-Butyl-N'-trimethylsilyl-6-methoxy-1,3,5-triazine-2,4-diamine
|
|
4 | 269.42 |
| 62-475-6 |
3-«beta»,17-«beta»-Dihydroxy-5-androsten-16-one, TMS
|
|
4 | 448.79 |
| 62-513-3 |
R,S-3',4'-methylenedioxy-«alpha»-pyrrolidinopropiophenone-M (desmethylene-methyl-), TMS
|
|
4 | 321.49 |
| 62-557-5 |
Phosphoramidothioic acid, o-ethyl-o-(2,4,5-trichlorophenyl) ester
|
2775-95-3 |
4 | 320.56 |
| 62-566-5 |
2,6-Pyridinedicarboxylic acid, ethyl 5-methoxy-3-methylpent-2-yl ester
|
|
4 | 309.36 |
| 62-839-2 |
(4,6-Dichloro-[1,3,5]triazin-2-yl)-(1,1,3,3-tetramethyl-butyl)-amine
|
|
4 | 277.19 |
| 63-147-9 |
1,5-Dimethyl-5-(6-oxocyclohexen-1-yl)hexahydropyrimidine-2,4,6-trione
|
|
4 | 250.25 |
| 63-477-3 |
5-«alpha»-Pregnane-17-«alpha»,20-«beta»,21-triol, tris-TMS
|
|
4 | 553.05 |
| 63-483-6 |
1,1,1-tris(Hydroxymethyl)propane, bis(tert-butyldimethylsilyl) ether
|
|
4 | 362.70 |
| 64-045-1 |
1-(4-Chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol, trimethylsilyl- ether
|
|
4 | 380.00 |
| 64-108-1 |
5-Chloro-N-(2-chloro-4-nitro-phenyl)-N-trimethylsilyl-2-trimethylsilyloxybenzamide
|
|
4 | 471.48 |
| 64-392-6 |
[1,3,5]Triazine-2,4-diamine, 6-chloro-N,N'-dicycloheptyl-
|
|
4 | 337.90 |
| 64-549-2 |
3,6,9-Trioxa-2,10-disilaundecane, 2,2,10,10-tetramethyl-
|
|
4 | 250.49 |
| 64-755-3 |
N2-Cyclopropyl-1,3,5-triazine-2,4,6-triamine N4,N6-diacetyl
|
|
4 | 250.26 |
| 64-814-7 |
3-Buten-2-one, 4-(2,6,6-trimethyl-2-cyclohexen-1-yl), PFBO # 2
|
|
4 | 387.39 |
| 64-891-2 |
2,6-Pyridinedicarboxylic acid, ethyl 2,4,4-trimethylpentyl ester
|
|
4 | 307.39 |
| 64-949-8 |
5-«alpha»-Pregnane-3-«beta»,17-«alpha»,20-«beta»-triol, methylboronate
|
|
4 | 360.34 |
| 65-097-3 |
2,3-Diazabicyclo[2.2.2]octane,2,3-dimethyl-,trans-
|
53779-85-4 |
4 | 140.23 |
| 65-196-3 |
Cinnamic acid, 4-methoxy-3-(tert-butyldimethylsilyl)oxy-, tert-butyldimethylsilyl ester
|
|
4 | 422.71 |
| 65-250-2 |
3«alpha»,16«beta»-Dihydroxy-5-androsten-17-one, di-TMS
|
|
4 | 448.79 |
| 65-325-9 |
Estra-1,3,5(10)-trien-17-one, 2-methoxy-3-[(trimethylsilyl)oxy]-
|
29825-40-9 |
4 | 372.57 |
| 65-421-2 |
Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, 2-methyl-4-oxo-3-(2-pentenyl)-2-cyclopenten-1-yl ester, [1R-[1«alpha»[S*(Z)],3«beta»]]-
|
4466-14-2 |
4 | 330.46 |
| 65-893-9 |
Androstane-11,17-dione, 3-[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»)-
|
5042-90-0 |
4 | 376.60 |
|
« Previous Results
Next Results »
|